54079

CAN VITAMIN D SUPPLEMENTATION REDUCE THE RISK OF FRACTURE IN THE POSTMENOPAUSAL WOMEN? AN EVIDENCE-BASED CLINICAL REVIEW.

Favorite this paper

Introduction and Objective: In 2010, it was estimated that 22 million women and 5.5 million men in the European Union (EU) had osteoporosis. Approximately 3.5 million new fragility fractures occur annually in the EU. Vitamin D supplements are widely available in all EU countries but guidelines regarding their use are not consistently established. This evidence-based clinical review aimed to clarify the role of Vitamin D in prevention of bone fractures in post-menopausal women. Method: A search was carried out during January 2016 on several Evidence Based Medicine websites. The gold was to identify articles of the last ten years in English, Portuguese and Spanish using the following MeSH terms “postmenopausal osteoporosis”, “vitamin D” and “bone fractures”. Meta-analysis, systematic reviews (SR), guidelines and randomized controlled trials (RCT) of vitamin D supplementation versus other treatments were selected. Evidence was classified using the SORT taxonomy. Results and conclusions: Two hundred and sixty two results were identified. Fifteen SR, eleven guidelines and ten RCT met the inclusion criteria. Although most guidelines advice on supplementation, SR showed that Vitamin D alone is unlikely to prevent fractures in the dosages and formulations tested so far. There is no consistent evidence to show the efficacy of vitamin D supplementation in the reduction of osteoporotic fractures in women (C). Oral vitamin D appears to reduce the risk of hip fractures only when calcium supplementation is added (B).